Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Herceptin
Related studies linked through entity extraction aliases.
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Demonstrate Efficacy and Safety of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Safety, Efficacy and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Adj TC + Herceptin Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Herceptin and GM-CSF for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2